Fight against HIV losing momentum; Robust analysis needed to develop long-term strategy

NewsGuard 100/100 Score

"After a decade of unprecedented increases in donor funding and a corresponding 17 percent decline worldwide in the number of new infections, the fight against HIV is losing momentum," Bjorn Lomborg, director of the Copenhagen Consensus Center and an adjunct professor at Copenhagen Business School, and Peter Piot, director of the London School of Hygiene and Tropical Medicine and former executive director of UNAIDS, write in this Wall Street Journal opinion piece.

"The response to AIDS is at a critical juncture. There are 33 million people living with the disease. HIV fatigue needs to be countered with robust analysis in order to support a long-term strategy," and "[t]he focus has to be on identifying those interventions that have the greatest effect on the pandemic for the amount of money spent," they write.  The authors reference a new initiative called RethinkHIV, launched by the Copenhagen Consensus Center, that "examines six areas of HIV intervention in the region of sub-Saharan Africa -- 47 countries with a combined population of 818 million -- and highlights some paths to better decision making" (9/23).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    New report on HIV drug resistance: Challenges and recommendations